WebMar 2, 2024 · Phesgo contains two active substances, pertuzumab and trastuzumab, which are already authorised for treating early and metastatic HER2-positive breast cancer and are available as infusion into a vein.Phesgo is as effective at treating breast cancer as the individual medicines given into a vein. Because it is given under the skin, it may be more … WebNov 1, 2024 · Administer Phesgo 1,200 mg, 600 mg, 30,000 units/15 mL subcutaneously over approximately 8 minutes Administer Phesgo 600 mg, 600 mg, 20,000 units/10 mL subcutaneously over approximately 5 minutes The subcutaneous injection site should be …
Did you know?
Webtrastuzumab, and 30,000 units hyaluronidase per 15 mL NDC 50242-0245-01 1 ready-to-use vial 600 mg pertuzumab, 600 mg trastuzumab, and 20,000 units hyaluronidase per 10 mL ... Payers might have different preferences for billing for PHESGO. Check with your local payers for specific billing unit information. CPT=Current Procedural Terminology ... WebIndications. Early Breast Cancer PHESGO TM (pertuzumab, trastuzumab, and hyaluronidase-zzxf) is indicated for use in combination with chemotherapy for. the neoadjuvant treatment of adult patients with HER2-positive, locally advanced, inflammatory, or early stage breast cancer (either greater than 2 cm in diameter or node-positive) as part …
WebLearn about Phesgo, potential side effects, proper use and dosing, and popular alternatives. Read reviews from GoodRx users who have taken Phesgo and find the latest news on the drug. ... 600 mg of trastuzumab, and 30,000 units of hyaluronidase. For all other doses, you’ll get 600 mg of pertuzumab, 600 mg of trastuzumab, and 20,000 units of ... WebNov 16, 2024 · PHESGO is compatible with stainless steel, polypropylene, polycarbonate, polyethylene, polyurethane, polyvinyl chloride and fluorinated ethylene polypropylene. Administration Administer PHESGO 1,200 mg, 600 mg, 30,000 units/15 mL …
Web1,200 mg pertuzumab/600 mg trastuzumab/30,000 units /15 mL: Administer SC over ~8 min; 600 mg pertuzumab/600 mg trastuzumab/30,000 units/10 mL: Administer SC over ~5 min; Sequence of administration. Anthracycline-based regimen (EBC): Administer Phesgo … WebMar 18, 2024 · Phesgo 1200 mg/600 mg solution for injection Active Ingredient: trastuzumab, pertuzumab Company: Roche Products Limited See contact details ATC code: L01XY02 About Medicine Prescription only medicine Healthcare Professionals (SmPC) Patient Leaflet (PIL) This information is for use by healthcare professionals Last updated …
WebMay 2, 2024 · VI. Billing Code/Availability Information HCPCS Code: J9316 – Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg; 1 billable unit = 10 mg NDC(s): Phesgo (1,200 mg pertuzumab, 600 mg trastuzumab, and 30,000 units hyaluronidase per …
WebGet information about the injection experience with PHESGO® (pertuzumab / trastuzumab / hyaluronidase-zzfx) and what to expect on treatment days. See Full Safety, including most serious side effects, for more information. growers world coventryWeb• The initial dose of PHESGO is 1,200 mg pertuzumab, 600 mg trastuzumab, and 30,000 units hyaluronidase administered subcutaneously over approximately 8 minutes, followed every 3 weeks by a dose of 600 mg pertuzumab, 600 mg trastuzumab, and 20,000 units … films pathe scheveningenWebMar 1, 2024 · PHESGO. PHESGO may harm the unborn baby. You should use effective contraception during treatment with PHESGO and for 7 months after stopping treatment. If you are a male patient taking PHESGO with a female partner who can become pregnant you should use effective contraception during treatment with PHESGO and for 7 months after … growers world danforthWebPhesgo is supplied as: 1,200 mg pertuzumab, 600 mg trastuzumab, and 30,000 units hyaluronidase/15mL (80 mg, 40 mg, and 2,000 units/mL) of solution in a single-dose vial. 600 mg pertuzumab, 600 mg trastuzumab, and 20,000 units hyaluronidase/10 mL (60 mg, … growers worldwide servicesWebPayers might have different preferences for billing for PHESGO. Check with your local payers for specific billing unit information. CPT=Current Procedural Terminology; HCPCS=Healthcare Common Procedure Coding System; ICD-10-CM=International films patheWebAug 25, 2024 · The initial dose of Phesgo™ is 1,200 mg pertuzumab, 600 mg trastuzumab, and 30,000 units hyaluronidase administered subcutaneously over approximately 8 minutes, followed every 3 weeks by a dose of 600 mg pertuzumab, 600 mg trastuzumab, and … films partly filmed in arizonaWebPhesgo is supplied as: 1,200 mg pertuzumab, 600 mg trastuzumab, and 30,000 units hyaluronidase/15mL (80 mg, 40 mg, and 2,000 units/mL) of solution in a single-dose vial. 600 mg pertuzumab, 600 mg trastuzumab, and 20,000 units hyaluronidase/10 mL (60 mg, 60 mg, and 2,000 units/mL) of solution in a single-dose vial films paris nord 2